1 “... total score of 22 points. Those patients treated with PLEX as their first-line therapy did not have...”

2 “...Biological activity of bisphenol A (BPA) structural analogues and functional alternatives...”

3 “...Biological activity of bisphenol A (BPA) structural analogues and functional alternatives...”

4 Subjects: “...Task Performance and Analysis...”

5 Subjects: “...Cost-Benefit Analysis...”

6 Subjects: “...Cost-Benefit Analysis...”

7 Subjects: “...Cost-Benefit Analysis...”

8

9 “... observed for haloperidol versus aripiprazole, olanzapine, or risperidone. FUNCTIONAL OUTCOMES AND HEALTH...”

10 “... observed for haloperidol versus aripiprazole, olanzapine, or risperidone. FUNCTIONAL OUTCOMES AND HEALTH...”

11 “...% CI, 0.53-2.46), 0.38 (95% CI, 0.22-0.65), and 0.10 (95% CI, 0.03-0.35), respectively (P...”

12 “... for cardiovascular protection, symptom relief, preservation of walking and functional status, and prevention...”

13 “... for cardiovascular protection, symptom relief, preservation of walking and functional status, and prevention...”

14 “.... Adverse effects were reported for the MDD subgroup in one duloxetine pooled analysis; these were similar...”

15 “.... Adverse effects were reported for the MDD subgroup in one duloxetine pooled analysis; these were similar...”

16 “... the mind's capacity to affect bodily function and symptoms. An increasing number of patients are using...”

17 “... the mind's capacity to affect bodily function and symptoms. An increasing number of patients are using...”

18

19 “... in adult trauma patients when BVM was compared with ETI.2. For neurological function, there was moderate...”

20